Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.

  • David R. Spigel
  • , Dianna L. Shipley
  • , David M. Waterhouse
  • , Suzanne F. Jones
  • , Patrick J. Ward
  • , Kent C. Shih
  • , Brian Hemphill
  • , Michael McCleod
  • , Robert C. Whorf
  • , Ray D. Page
  • , Joseph Stilwill
  • , Joseph Stilwill
  • , Tarek Mekhail
  • , Cindy Jacobs
  • , Howard A. Burris
  • , John D. Hainsworth
  • Sarah Cannon Research Institute
  • Florida Hospital Cancer Institute Orlando Florida USA
  • Oncogenex Bothell Washington USA

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalOncologist
Volume24
Issue number12
DOIs
StatePublished - Dec 1 2019

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this